StemCells (NASDAQ: STEM) has completed transplantation of the first subject in its Radiant Study at the Retina Foundation of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE